Where necessary, it should be possible for the Committee for Advanced Therapies to make completion of its evaluation subject to a site visit of the premises where the advanced therapy medicinal product is being developed.
Recital 6, Commission Regulation (EC) No 668/2009 of 24 July 2009 implementing Regulation (EC) No 1…
In forcesince 24 Jul 2009